UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000031244
Receipt number R000035672
Scientific Title A randomized trial estimating the efficiency of drainage around the cervical anastomosis in esophagectomy for esophageal cancer (Transitioned to jRCT)
Date of disclosure of the study information 2018/05/01
Last modified on 2023/02/15 10:46:53

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

A randomized trial estimating the efficiency of drainage around the cervical anastomosis in esophagectomy for esophageal cancer (Transitioned to jRCT)

Acronym

A randomized trial estimating the efficiency of drainage around the cervical anastomosis in esophagectomy for esophageal cancer

Scientific Title

A randomized trial estimating the efficiency of drainage around the cervical anastomosis in esophagectomy for esophageal cancer (Transitioned to jRCT)

Scientific Title:Acronym

A randomized trial estimating the efficiency of drainage around the cervical anastomosis in esophagectomy for esophageal cancer

Region

Japan


Condition

Condition

esophageal cancer

Classification by specialty

Surgery in general

Classification by malignancy

Malignancy

Genomic information

NO


Objectives

Narrative objectives1

The purpose of this study is to improve the noninferiority of drainage tube detention to non-detention in anastomotic leakage rate for clinical stage I/II/III esophageal cancer

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

anastomotic leakage rate

Key secondary outcomes



Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Cluster

Blinding

Open -no one is blinded

Control

No treatment

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

2

Purpose of intervention

Treatment

Type of intervention

Device,equipment

Interventions/Control_1

Detention of the silicon drain around the cervical anastomosis

Interventions/Control_2

Intervention period is less than 14days.

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

85 years-old >=

Gender

Male and Female

Key inclusion criteria

The diagnosis of esophageal cancer(squamous cell carcinoma, adenosquamous cell carcinoma, basaloid carcinoma) was based on the seventh edition of the Union for International Cancer Control (UICC) tumor node metastasis (TNM) cancer staging system. In this study, inclusion criteria included thoracic esophageal cancer, multiple esophageal cancer, age 18-75 years; cStage I-III disease (without T4); and Informed consent was obtained from all individual participants included in the study.

Key exclusion criteria

Patients who don't satisfied above criteria should be excluded.

Target sample size

76


Research contact person

Name of lead principal investigator

1st name Taro
Middle name
Last name Oshikiri

Organization

Graduate School of Medicine, Kobe University

Division name

Division of Gastrointestinal Surgery, Department of Surgery,

Zip code

650-0017

Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017

TEL

078-382-5925

Email

urotarikishio@gmail.com


Public contact

Name of contact person

1st name Taro
Middle name
Last name Oshikiri

Organization

Graduate School of Medicine, Kobe University

Division name

Division of Gastrointestinal Surgery, Department of Surgery,

Zip code

6500017

Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017

TEL

078-382-5925

Homepage URL


Email

urotarikishio@gmail.com


Sponsor or person

Institute

Graduate School of Medicine, Kobe University

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Medicine, Kobe University

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Kobe University Clinical Research Review Committee

Address

7-5-2, Kusunoki-cho, Chuo-ku, Kobe, Hyogo, 650-0017

Tel

078-382-6669

Email

cerb@med.kobe-u.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2018 Year 05 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2018 Year 04 Month 01 Day

Date of IRB

2018 Year 12 Month 19 Day

Anticipated trial start date

2018 Year 04 Month 01 Day

Last follow-up date

2023 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Transitioned to jRCT, jRCTs1052180016


Management information

Registered date

2018 Year 02 Month 10 Day

Last modified on

2023 Year 02 Month 15 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000035672


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name